CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-02 | Ragosa Mark CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −900 | $34.28 | $31K | 31,086 |
| 2025-09-02 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | −1,861 | 0 | ||
| 2025-09-02 | Patel Sanj K CHAIRMAN & CEO | Option exercise | +6,569 | 114,971 | ||
| 2025-09-02 | Patel Sanj K CHAIRMAN & CEO | Shares withheld for taxes | −3,177 | $34.28 | $109K | 111,794 |
| 2025-09-02 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −6,569 | 0 | ||
| 2025-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +1,746 | 41,961 | ||
| 2025-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +1,773 | 43,734 | ||
| 2025-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +2,726 | 46,460 | ||
| 2025-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Shares withheld for taxes 10b5-1 | −3,022 | $33.49 | $101K | 43,438 |
| 2025-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Grant or award · Restricted Share Unit 10b5-1 | +9,828 | 9,828 | ||
| 2025-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Grant or award · Share Option 10b5-1 | +39,364 | 39,364 | ||
| 2025-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit 10b5-1 | +1,746 | 5,235 | ||
| 2025-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit 10b5-1 | −1,773 | 3,545 | ||
| 2025-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit 10b5-1 | −2,726 | 2,726 | ||
| 2025-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +2,363 | 35,404 | ||
| 2025-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +2,557 | 37,961 | ||
| 2025-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +3,933 | 41,894 | ||
| 2025-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes 10b5-1 | −4,282 | $33.49 | $143K | 37,612 |
| 2025-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award · Restricted Share Unit 10b5-1 | +10,575 | 10,575 | ||
| 2025-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award · Share Option 10b5-1 | +21,150 | 21,150 |
Page 24 of 74 · 1,467 trades